These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12507537)

  • 1. Antimuscarinics and the overactive detrusor--which is the main mechanism of action?
    Andersson KE; Yoshida M
    Eur Urol; 2003 Jan; 43(1):1-5. PubMed ID: 12507537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local effects of antimuscarinics.
    Masuda H; Kim YT; Tyagi S; Chancellor MB; de Miguel F; Yoshimura N
    Urol Clin North Am; 2006 Nov; 33(4):511-8, ix-x. PubMed ID: 17011387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic agonists and antagonists: effects on the urinary bladder.
    Sellers DJ; Chess-Williams R
    Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimuscarinics and overactive bladder: other mechanism of action.
    Yamaguchi O
    Neurourol Urodyn; 2010; 29(1):112-5. PubMed ID: 19693952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimuscarinic mechanisms and the overactive detrusor: an update.
    Andersson KE
    Eur Urol; 2011 Mar; 59(3):377-86. PubMed ID: 21168951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder.
    Yoshida M; Masunaga K; Nagata T; Yono M; Homma Y
    J Pharmacol Sci; 2010; 112(2):128-34. PubMed ID: 20134115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptors: what we know.
    Scarpero HM; Dmochowski RR
    Curr Urol Rep; 2003 Dec; 4(6):421-8. PubMed ID: 14622493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrusor myocyte activity and afferent signaling.
    Andersson KE
    Neurourol Urodyn; 2010; 29(1):97-106. PubMed ID: 20025035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emptying against outflow obstruction--pharmacological aspects.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1997; 184():77-84. PubMed ID: 9165626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity.
    Abrams P
    Urology; 2003 Nov; 62(5 Suppl 2):28-37; discussion 40-2. PubMed ID: 14662404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptors in the bladder: from basic research to therapeutics.
    Hegde SS
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overactive bladder inhibition in response to pelvic floor muscle exercises.
    Shafik A; Shafik IA
    World J Urol; 2003 May; 20(6):374-7. PubMed ID: 12682771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives.
    Kwon J; Kim DY; Cho KJ; Hashimoto M; Matsuoka K; Kamijo T; Wang Z; Karnup S; Robertson AM; Tyagi P; Yoshimura N
    Int Neurourol J; 2024 Feb; 28(Suppl 1):12-33. PubMed ID: 38461853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity.
    Daly DM; Chess-Williams R; Chapple C; Grundy D
    Eur Urol; 2010 Jul; 58(1):22-8; discussion 31-2. PubMed ID: 20071074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimuscarinic actions on bladder urothelium and lamina propria contractions are similar to those observed in detrusor smooth muscle preparations.
    Veer V; Chess-Williams R; Moro C
    Neurourol Urodyn; 2023 Jun; 42(5):1080-1087. PubMed ID: 36975140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.